Sunila Mahavadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sunila Mahavadi has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Karnam S. Murthy
Department of Physiology and Biophysics, VCU Program in Enteric Neuromuscular Sciences, Virginia Commonwealth University, Richmond, VA, USA
3 shared publicationsHongxia Wang
Department of Physiology and Biophysics, VCU Program in Enteric Neuromuscular Sciences, Virginia Commonwealth University, Richmond, VA, USA
2 shared publicationsJohn R. Grider
Department of Physiology and Biophysics, VCU Program in Enteric Neuromuscular Sciences, Virginia Commonwealth University, Richmond, Virginia
2 shared publications- John R. Grider
Department of Physiology and Biophysics, Division of Gastroenterology, VCU Program in Enteric Neuromuscular Sciences (VPENS), Virginia Commonwealth University, Richmond, VA 23298, USA
2 shared publications - Karnam S. Murthy
Virginia Commonwealth University Richmond Virginia USA
2 shared publications Kulpreet Singh
Department of Physiology and Biophysics, VCU Program in Enteric Neuromuscular Sciences, Virginia Commonwealth University, Richmond, VA, USA
2 shared publications
Latest Publications
- Open Access
- 12 November 2019
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 32 (2) , e13737
Expression and function of umami receptors T1R1/T1R3 in gastric smooth muscle
Background: l‐amino acids, such as monosodium glutamate (MSG), activate the umami receptor T1R1/T1R3. We previously showed increased peristalsis in response to activation of T1R1/T1R3 by MSG in mouse colon. However, the expression and function of these receptors in the different regions of the stomach are not clear.Methods: Mouse gastric smooth muscle cells (SMCs) were isolated and cultured in Dulbecco’s Modified Eagle Medium. Expression of T1R1 and T1R3 was measured by RT‐PCR and Western blot. The effect of MSG with and without inosine monophosphate (IMP, an allosteric activator of T1R1/T1R3) on acetylcholine (ACh)‐induced contraction was measured in muscle strips and isolated SMCs by scanning micrometry. The effect of MSG with or without IMP on activation of G proteins and ACh‐induced Ca2+ release was measured in SMCs.Key Results: Monosodium glutamate inhibited ACh‐induced contractions in muscle strips from both antrum and fundus and the effect of MSG was augmented by IMP; the effects were concentration‐dependent and not affected by the nitric oxide synthase inhibitor, L‐NNA, or tetrodotoxin suggesting a direct effect on SMCs. In isolated gastric SMCs, T1R1 and T1R3 transcripts and protein were identified. Addition of MSG with or without IMP inhibited ACh‐induced Ca2+ release and muscle contraction; the effect on contraction was blocked by pertussis toxin suggesting activation of Gαi proteins. MSG in the presence of IMP selectively activated Gαi2.Conclusions and Inferences: Umami receptors (T1R1/T1R3) are present on SMCs of the stomach, and activation of these receptors induces muscle relaxation by decreasing [Ca2+]i via Gαi2.
- 12 November 2019
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 32 (2) , e13737
Open AccessExpression and function of umami receptors T1R1/T1R3 in gastric smooth muscle
Background: l‐amino acids, such as monosodium glutamate (MSG), activate the umami receptor T1R1/T1R3. We previously showed increased peristalsis in response to activation of T1R1/T1R3 by MSG in mouse colon. However, the expression and function of these receptors in the different regions of the stomach are not clear.Methods: Mouse gastric smooth muscle cells (SMCs) were isolated and cultured in Dulbecco’s Modified Eagle Medium. Expression of T1R1 and T1R3 was measured by RT‐PCR and Western blot. The effect of MSG with and without inosine monophosphate (IMP, an allosteric activator of T1R1/T1R3) on acetylcholine (ACh)‐induced contraction was measured in muscle strips and isolated SMCs by scanning micrometry. The effect of MSG with or without IMP on activation of G proteins and ACh‐induced Ca2+ release was measured in SMCs.Key Results: Monosodium glutamate inhibited ACh‐induced contractions in muscle strips from both antrum and fundus and the effect of MSG was augmented by IMP; the effects were concentration‐dependent and not affected by the nitric oxide synthase inhibitor, L‐NNA, or tetrodotoxin suggesting a direct effect on SMCs. In isolated gastric SMCs, T1R1 and T1R3 transcripts and protein were identified. Addition of MSG with or without IMP inhibited ACh‐induced Ca2+ release and muscle contraction; the effect on contraction was blocked by pertussis toxin suggesting activation of Gαi proteins. MSG in the presence of IMP selectively activated Gαi2.Conclusions and Inferences: Umami receptors (T1R1/T1R3) are present on SMCs of the stomach, and activation of these receptors induces muscle relaxation by decreasing [Ca2+]i via Gαi2.
- Open Access
- 1 April 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (S1) , lb548
Altered Contraction Phenotype and Smooth Muscle Function in the Intestine of Dystrophin‐Deficient ( mdx ) Mice
Duchenne Muscular Dystrophy (DMD), characterized by progressive skeletal muscle degeneration and weakness, is caused by a deficiency in the dystrophin gene. Dystrophin is a structural protein that connects the extracellular matrix to the cytoskeletal proteins and plays a protective role in mechanotransduction. Muscle cells are more susceptible to contraction‐induced damage due to lack of functional dystrophin. Although the prominent symptoms of DMD are related to skeletal muscle, loss of dystrophin also affects cardiac, vascular and visceral smooth muscle function. The animal model that is extensively used to study the pathophysiology of DMD is mdx mice which contains a mutation in the dystrophin gene on exon 23 causing a loss of dystrophin expression. In patients with DMD and in mdx mice, loss of dystrophin is associated with gastrointestinal motility disorders such as delayed gastric emptying, decrease in intestinal transit and chronic constipation. In the gastrointestinal tract, enteric neurons, interstitial cells of Cajal and smooth muscle cells are shown to express dystrophin. The AIM of the present study was to investigate whether the lack of dystrophin affects contractile phenotype and smooth muscle function using isolated intestinal muscle cells from wild type (WT) and mdx mice. Inflammation has been identified as one of the mechanisms for the disease progression in DMD; therefore, we also investigated the effect of MG132 and IKKIV, inhibitors of pro‐inflammatory NF‐κB signaling pathway, in mdx mice. METHODS: Intestinal smooth muscle cells were isolated from WT and mdx mice. Expression of the p65 subunit of NF‐κB and smooth muscle markers such as smoothelin, tropomyosin, calponin, caldesmon and SM22α were measured by qRT‐PCR and western blot. Smooth muscle function was measured as contraction (decrease in cell length) in response to a cholinergic agonist, acetylcholine, by scanning micrometry. Muscle strips from mdx mice were incubated with MG132 (10 μM) or IKKIV (10 μM) in vitro for 24 h and expression of smooth muscle markers was measured. RESULTS: The mRNA and protein levels of tropomyosin, calponin, caldesmon, smoothelin, and SM22α were significantly decreased in intestinal smooth muscle of mdx mice compared to WT mice. The decrease in expression of smooth muscle markers was associated with a significant decrease in both Ca 2+ ‐dependent and ‐independent contraction in response to acetylcholine. The expression of the p65 subunit of NF‐κB was increased in smooth muscle from mdx mice, while treatment of muscle strips of mdx mice with NF‐κB inhibitors (MG132 or IKKVI) reversed the decrease in the mRNA and protein levels of smooth muscle markers to levels similar to that in smooth muscle from WT mice. CONCLUSION: Lack of dystrophin causes an increase in NF‐κB expression and a decrease in contractile phenotype and smooth muscle function in the intestine. Inhibition of NF‐κB pathway in the intestine of mdx mice restores contractile phenotype. Targeting NF‐κB signaling pathway may offer a potential therapeutic strategy to treat gastrointestinal motility disorders in DMD patients. Support or Funding Information DK28300 and DK15564 This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
- 1 April 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (S1) , lb548
Open AccessAltered Contraction Phenotype and Smooth Muscle Function in the Intestine of Dystrophin‐Deficient ( mdx ) Mice
Duchenne Muscular Dystrophy (DMD), characterized by progressive skeletal muscle degeneration and weakness, is caused by a deficiency in the dystrophin gene. Dystrophin is a structural protein that connects the extracellular matrix to the cytoskeletal proteins and plays a protective role in mechanotransduction. Muscle cells are more susceptible to contraction‐induced damage due to lack of functional dystrophin. Although the prominent symptoms of DMD are related to skeletal muscle, loss of dystrophin also affects cardiac, vascular and visceral smooth muscle function. The animal model that is extensively used to study the pathophysiology of DMD is mdx mice which contains a mutation in the dystrophin gene on exon 23 causing a loss of dystrophin expression. In patients with DMD and in mdx mice, loss of dystrophin is associated with gastrointestinal motility disorders such as delayed gastric emptying, decrease in intestinal transit and chronic constipation. In the gastrointestinal tract, enteric neurons, interstitial cells of Cajal and smooth muscle cells are shown to express dystrophin. The AIM of the present study was to investigate whether the lack of dystrophin affects contractile phenotype and smooth muscle function using isolated intestinal muscle cells from wild type (WT) and mdx mice. Inflammation has been identified as one of the mechanisms for the disease progression in DMD; therefore, we also investigated the effect of MG132 and IKKIV, inhibitors of pro‐inflammatory NF‐κB signaling pathway, in mdx mice. METHODS: Intestinal smooth muscle cells were isolated from WT and mdx mice. Expression of the p65 subunit of NF‐κB and smooth muscle markers such as smoothelin, tropomyosin, calponin, caldesmon and SM22α were measured by qRT‐PCR and western blot. Smooth muscle function was measured as contraction (decrease in cell length) in response to a cholinergic agonist, acetylcholine, by scanning micrometry. Muscle strips from mdx mice were incubated with MG132 (10 μM) or IKKIV (10 μM) in vitro for 24 h and expression of smooth muscle markers was measured. RESULTS: The mRNA and protein levels of tropomyosin, calponin, caldesmon, smoothelin, and SM22α were significantly decreased in intestinal smooth muscle of mdx mice compared to WT mice. The decrease in expression of smooth muscle markers was associated with a significant decrease in both Ca 2+ ‐dependent and ‐independent contraction in response to acetylcholine. The expression of the p65 subunit of NF‐κB was increased in smooth muscle from mdx mice, while treatment of muscle strips of mdx mice with NF‐κB inhibitors (MG132 or IKKVI) reversed the decrease in the mRNA and protein levels of smooth muscle markers to levels similar to that in smooth muscle from WT mice. CONCLUSION: Lack of dystrophin causes an increase in NF‐κB expression and a decrease in contractile phenotype and smooth muscle function in the intestine. Inhibition of NF‐κB pathway in the intestine of mdx mice restores contractile phenotype. Targeting NF‐κB signaling pathway may offer a potential therapeutic strategy to treat gastrointestinal motility disorders in DMD patients. Support or Funding Information DK28300 and DK15564 This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
- RetractedOpen Access
- 20 December 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (12) , e0209359
Regulation of gastric smooth muscle contraction via Ca2+-dependent and Ca2+-independent actin polymerization
In gastrointestinal smooth muscle, acetylcholine induced muscle contraction is biphasic, initial peak followed by sustained contraction. Contraction is regulated by phosphorylation of 20 kDa myosin light chain (MLC) at Ser19, interaction of actin and myosin, and actin polymerization. The present study characterized the signaling mechanisms involved in actin polymerization during initial and sustained muscle contraction in response to muscarinic M3 receptor activation in gastric smooth muscle cells by targeting the effectors of initial (phospholipase C (PLC)-β/Ca2+ pathway) and sustained (RhoA/focal adhesion kinase (FAK)/Rho kinase pathway) contraction. The initial Ca2+ dependent contraction and actin polymerization is mediated by sequential activation of PLC-β1 via Gαq, IP3 formation, Ca2+ release and Ca2+ dependent phosphorylation of proline-rich-tyrosine kinase 2 (Pyk2) at Tyr402. The sustained Ca2+ independent contraction and actin polymerization is mediated by activation of RhoA, and phosphorylation of FAK at Tyr397. Both phosphorylation of Pyk2 and FAK leads to phosphorylation of paxillin at Tyr118 and association of phosphorylated paxillin with the GEF proteins p21-activated kinase (PAK) interacting exchange factor α, β (α and β PIX) and DOCK 180. These GEF proteins stimulate Cdc42 leading to the activation of nucleation promoting factor N-WASP (neuronal Wiskott-Aldrich syndrome protein), which interacts with actin related protein complex 2/3 (Arp2/3) to induce actin polymerization and muscle contraction. Acetylcholine induced muscle contraction is inhibited by actin polymerization inhibitors. Thus, our results suggest that a novel mechanism for the regulation of smooth muscle contraction is mediated by actin polymerization in gastrointestinal smooth muscle which is independent of MLC20 phosphorylation.
- 20 December 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (12) , e0209359
RetractedOpen AccessRegulation of gastric smooth muscle contraction via Ca2+-dependent and Ca2+-independent actin polymerization
In gastrointestinal smooth muscle, acetylcholine induced muscle contraction is biphasic, initial peak followed by sustained contraction. Contraction is regulated by phosphorylation of 20 kDa myosin light chain (MLC) at Ser19, interaction of actin and myosin, and actin polymerization. The present study characterized the signaling mechanisms involved in actin polymerization during initial and sustained muscle contraction in response to muscarinic M3 receptor activation in gastric smooth muscle cells by targeting the effectors of initial (phospholipase C (PLC)-β/Ca2+ pathway) and sustained (RhoA/focal adhesion kinase (FAK)/Rho kinase pathway) contraction. The initial Ca2+ dependent contraction and actin polymerization is mediated by sequential activation of PLC-β1 via Gαq, IP3 formation, Ca2+ release and Ca2+ dependent phosphorylation of proline-rich-tyrosine kinase 2 (Pyk2) at Tyr402. The sustained Ca2+ independent contraction and actin polymerization is mediated by activation of RhoA, and phosphorylation of FAK at Tyr397. Both phosphorylation of Pyk2 and FAK leads to phosphorylation of paxillin at Tyr118 and association of phosphorylated paxillin with the GEF proteins p21-activated kinase (PAK) interacting exchange factor α, β (α and β PIX) and DOCK 180. These GEF proteins stimulate Cdc42 leading to the activation of nucleation promoting factor N-WASP (neuronal Wiskott-Aldrich syndrome protein), which interacts with actin related protein complex 2/3 (Arp2/3) to induce actin polymerization and muscle contraction. Acetylcholine induced muscle contraction is inhibited by actin polymerization inhibitors. Thus, our results suggest that a novel mechanism for the regulation of smooth muscle contraction is mediated by actin polymerization in gastrointestinal smooth muscle which is independent of MLC20 phosphorylation.
- 4 November 2018
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (2) , e13495
Muscarinic m2 receptor‐mediated actin polymerization via PI3 kinase γ and integrin‐linked kinase in gastric smooth muscle
Background: Actin polymerization plays an important role in smooth muscle contraction. Integrin‐linked kinase (ILK) was shown to mediate actin polymerization in airway smooth muscle. The role of ILK in actin polymerization in response to m2 receptor activation was not in gastric smooth muscle.Methods: Phosphorylation of paxillin, neuronal Wiskott‐Aldrich syndrome protein (N‐WASp), and association of paxillin with GEF proteins (Cool2/αPix [Cool2/PAK‐interacting exchange factor alpha], Cool1/βPix [Cool1/PAK‐interacting exchange factor beta], and DOCK 180 [Dedicator of cytokinesis]) and N‐WASp with Arp2/3 complex were measured by western blot. Activation of Cdc42 was determined using an antibody for activated Cdc42. Actin polymerization was measured as an increase in F‐actin/G‐actin ratio.Results: Phosphorylation of paxillin, an association of paxillin with GEF proteins, Cdc42 activity, and actin polymerization were increased in response to m2 receptor activation in gastric smooth muscle cells. The increases in paxillin phosphorylation, Cdc42 activity, and actin polymerization were inhibited by a PI3Kγ inhibitor (AS‐605240), ILK siRNA, and ILK dominant negative mutant (ILK [R211]). Increase in actin polymerization was also inhibited by Cdc42 dominant negative mutant (Cdc42 [T17N]). Increases in the association of paxillin with GEF proteins, phosphorylation of N‐WASp and its association with Arp2/3 complex were inhibited by ILK (R211).Conclusion: In gastric smooth muscle cells, activation of PI3Kγ by muscarinic m2 receptors causes ILK‐dependent phosphorylation of paxillin, an association of paxillin with Cdc42 GEF proteins and activation of Cdc42, which, in turn, causes phosphorylation of N‐WASp and its association with Arp2/3 complex leading to actin polymerization.
- 4 November 2018
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (2) , e13495
Muscarinic m2 receptor‐mediated actin polymerization via PI3 kinase γ and integrin‐linked kinase in gastric smooth muscle
Background: Actin polymerization plays an important role in smooth muscle contraction. Integrin‐linked kinase (ILK) was shown to mediate actin polymerization in airway smooth muscle. The role of ILK in actin polymerization in response to m2 receptor activation was not in gastric smooth muscle.Methods: Phosphorylation of paxillin, neuronal Wiskott‐Aldrich syndrome protein (N‐WASp), and association of paxillin with GEF proteins (Cool2/αPix [Cool2/PAK‐interacting exchange factor alpha], Cool1/βPix [Cool1/PAK‐interacting exchange factor beta], and DOCK 180 [Dedicator of cytokinesis]) and N‐WASp with Arp2/3 complex were measured by western blot. Activation of Cdc42 was determined using an antibody for activated Cdc42. Actin polymerization was measured as an increase in F‐actin/G‐actin ratio.Results: Phosphorylation of paxillin, an association of paxillin with GEF proteins, Cdc42 activity, and actin polymerization were increased in response to m2 receptor activation in gastric smooth muscle cells. The increases in paxillin phosphorylation, Cdc42 activity, and actin polymerization were inhibited by a PI3Kγ inhibitor (AS‐605240), ILK siRNA, and ILK dominant negative mutant (ILK [R211]). Increase in actin polymerization was also inhibited by Cdc42 dominant negative mutant (Cdc42 [T17N]). Increases in the association of paxillin with GEF proteins, phosphorylation of N‐WASp and its association with Arp2/3 complex were inhibited by ILK (R211).Conclusion: In gastric smooth muscle cells, activation of PI3Kγ by muscarinic m2 receptors causes ILK‐dependent phosphorylation of paxillin, an association of paxillin with Cdc42 GEF proteins and activation of Cdc42, which, in turn, causes phosphorylation of N‐WASp and its association with Arp2/3 complex leading to actin polymerization.
- Open Access
- 5 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0178574
Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle
The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity. Here we studied the effect of hyperglycemia on smooth muscle function. Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction. RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG. Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice. Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice. The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo, suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression. Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle. Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction. NAC treatment also reversed the decrease in gastric emptying in ob/ob mice. We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.
- 5 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0178574
Open AccessDiabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle
The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity. Here we studied the effect of hyperglycemia on smooth muscle function. Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction. RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG. Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice. Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice. The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo, suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression. Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle. Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction. NAC treatment also reversed the decrease in gastric emptying in ob/ob mice. We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.
- Open Access
- 1 December 2009
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 297 (6) , G1232-G1238
Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of Gαi3
In human intestinal smooth muscle cells, endogenous insulin-like growth factor-I (IGF-I) regulates growth and IGF-binding protein-5 (IGFBP-5) expression. The effects of IGF-I are facilitated by IGFBP-5. We previously showed that IGFBP-5 acts independently of IGF-I in human intestinal muscle to stimulate proliferation and upregulate IGF-I production by activation of Erk1/2 and p38 MAPK. Thus a positive feedback loop exists between IGF-I and IGFBP-5, whereby both stimulate muscle growth and production of the other factor. In Crohn's disease, IGF-I and IGFBP-5 expression are increased and contribute to stricture formation through this effect on muscle growth. To determine the signaling pathways coupling IGFBP-5 to MAPK activation and growth, smooth muscle cells were isolated from muscularis propria of human intestine and placed into primary culture. Erk1/2 and p38 MAPK activation and type I collagen production were measured by immunoblot. Proliferation was measured by [3H]thymidine incorporation. Activation of specific G proteins was measured by ELISA. AG1024, an IGF-I receptor tyrosine kinase inhibitor, was used to isolate the IGF-I-independent effects of IGFBP-5. IGFBP-5-induced phosphorylation of Erk1/2 and p38 MAPK and proliferation were abolished by pertussis toxin, implying the participation of Gi. IGFBP-5 specifically activated Gi3 but not other G proteins. Transfection of an inhibitory Gαi minigene specifically inhibited MAPK activation, proliferation, and both collagen-I and IGF-I production. Our results indicate that endogenous IGFBP-5 activates Gi3 and regulates smooth muscle growth, IGF-I production, and collagen production via the α-subunit of Gi3, independently of IGF-I, in normal human intestinal muscle cells.
- 1 December 2009
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 297 (6) , G1232-G1238
Open AccessInsulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of Gαi3
In human intestinal smooth muscle cells, endogenous insulin-like growth factor-I (IGF-I) regulates growth and IGF-binding protein-5 (IGFBP-5) expression. The effects of IGF-I are facilitated by IGFBP-5. We previously showed that IGFBP-5 acts independently of IGF-I in human intestinal muscle to stimulate proliferation and upregulate IGF-I production by activation of Erk1/2 and p38 MAPK. Thus a positive feedback loop exists between IGF-I and IGFBP-5, whereby both stimulate muscle growth and production of the other factor. In Crohn's disease, IGF-I and IGFBP-5 expression are increased and contribute to stricture formation through this effect on muscle growth. To determine the signaling pathways coupling IGFBP-5 to MAPK activation and growth, smooth muscle cells were isolated from muscularis propria of human intestine and placed into primary culture. Erk1/2 and p38 MAPK activation and type I collagen production were measured by immunoblot. Proliferation was measured by [3H]thymidine incorporation. Activation of specific G proteins was measured by ELISA. AG1024, an IGF-I receptor tyrosine kinase inhibitor, was used to isolate the IGF-I-independent effects of IGFBP-5. IGFBP-5-induced phosphorylation of Erk1/2 and p38 MAPK and proliferation were abolished by pertussis toxin, implying the participation of Gi. IGFBP-5 specifically activated Gi3 but not other G proteins. Transfection of an inhibitory Gαi minigene specifically inhibited MAPK activation, proliferation, and both collagen-I and IGF-I production. Our results indicate that endogenous IGFBP-5 activates Gi3 and regulates smooth muscle growth, IGF-I production, and collagen production via the α-subunit of Gi3, independently of IGF-I, in normal human intestinal muscle cells.